Assistant Professor of Psychiatry and Behavioral Sciences
Department / Division:
/ Behavioral Medicine
- MD, Università Degli Studi di Firenze (Italy), 1991
Tal Burt, MD is a Board-Certified psychiatrist and clinical researcher trained in Israel, Italy, France, and the United States. After joining the faculty at the Department of Psychiatry at Columbia University, Dr. Burt joined Pfizer Inc., and then Eisai Pharmaceuticals, as Senior Medical Director with responsibilities in all phases of clinical research and development. He then joined Duke and was the founding director of the Investigational Medicine Unit (IMU) in Singapore and the Medanta Duke Research Institute (MDRI) in India, both early-phase, Proof-of-Concept (POC) clinical research units. Currently he is the Scientific Director of the Duke Global POC Research Network. His interests include microdosing – an innovative drug development approach that uses sub-pharmacological doses of novel pharmaceuticals to study them before the traditional first-in-man studies. He has founded the PARTAKE initiative (Public Awareness of Research for Therapeutic Advancements through Knowledge and Empowerment) an educational program that promotes public understanding and participation in clinical research, and CREATE program (Continuous Research Education and Training Exercises).